The global retinal surgery devices market size is expected to reach USD 4.22 billion in 2030 and is projected to grow at a CAGR of 5.5% from 2024 to 2030. The unprecedented growth is presumed to be a consequence of the growing prevalence of retinal eye disorders such as retinal detachment, macular degeneration, amblyopia, and others. Rising patient preference for minimally invasive surgeries is believed to be one of the major growth of contributory factors. The increasing demand is predicted to be a result of associated benefits such as improved cost-efficiency, safety, rapid recovery, efficacy, and reduced hospital stay. Other advantages include fewer incision wounds and reduced postsurgical complications that lead to higher patient satisfaction.
The market is also driven by technological upgradations that are responsible for the heightened inclination of physicians, thereby, widening the scope for greater adoption of retinal surgery devices in the future. The technologically advanced devices are equipped with fundus imaging units, micro-incision technology, endoillumination systems. These advancements are primarily witnessed in surgical instrumentation to facilitate easy & safe operative procedures. For instance, the launch of VersaVIT 2.0 vitrectomy machine is equipped with an LED illumination system, 3 vitrectomy packs, and adjustable chandelier fiber. Similarly, 23-Gauge fragmentation needle eliminates the need to enlarge sclerotomy and achieve enhanced visualization, intraoperative efficiency, and control.
Request a free sample copy or view report summary: Retinal Surgery Devices Market Report
Retinal laser equipment is predicted to observe exponential growth owing to consistency in the usage of a wide range of retinal operative procedures, high cost-efficiency, availability, and easy operability of the products
Diabetic retinopathy emerged as the largest application segment in 2023 as a consequence of high prevalence, raising the clinical urgency to adopt retinal surgery devices, thereby, fueling their penetration scope over the coming years
Hospitals held the largest share in the end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment
North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide a platform for growth through consistent new product approvals
The market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration
The competition is marked by companies indulging in a number of mergers & acquisitions, distribution agreements, and product approvals leading to significant growth
For instance, in February 2017, IRIDEX Corporation received FDA approval for its CYCLO G6 which has combined trans-illumination and laser fiber thereby expanding their product portfolio
Grand View Research has segmented the global retinal surgery devices report based on product, application, end use and region:
Retinal Surgery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Vitrectomy Machines
Vitrectomy Packs
Surgical Instruments
Microscopic Illumination Equipment
Retinal Laser Equipment
Others
Retinal Surgery Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Clinical
Diabetic Retinopathy
Retinal Detachment
Epiretinal Membrane
Macular Hole
Others
Retinal Surgery Devices End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Eye Clinics
Others
Retinal Surgery Devices Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Retinal Surgery Devices Market
Alcon Inc.
Carl Zeiss Meditec AG
Bausch + Lomb
TOPCON CORPORATION
IRIDEX Corporation
Escalon Medical Corp
Lumenis Be Ltd.
NIDEK CO., LTD.
"The quality of research they have done for us has been excellent..."